FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Novo Nordisk India Sales Jump 40% in April After Wegovy, Ozempic Price Cuts

By

Novo Nordisk's diabetes and obesity drug sales recorded a sharp rise in India sales in April after it reduced prices of Wegovy and Ozempic to counter growing competition from generic semaglutide therapies, Bloomberg News reported Friday, citing Pharmarack data.

Sales of Wegovy, Ozempic and partner-branded products climbed 40% monthly to 32,000 units in April, which was the first full month since the Danish pharmaceutical group lowered starter-dose prices by up to 48%, the report noted.

India's overall GLP-1 market expanded 56% month over month in April to 414,000 units, driven by low-cost generic semaglutide products, the report noted. Eli Lilly remained the country's top-selling GLP-1 drugmaker.

Novo Nordisk did not immediately respond to' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Cyber Power Systems Hit By Cyberattack

Cyber Power Systems (TPE:3617) said unidentified hackers gained unauthorized access to parts of its systems and encrypted certain server data, according to a Thursday Taiwan Exchange filing.Shares gained over 1% in Friday's late morning trade.The company activated its cybersecurity response and recovery mechanisms immediately after the breach was discovered. External cybersecurity firms and experts were also brought in to assist with the investigation and remediation efforts.Cyber Power said the incident is not expected to have any material impact on its financial condition or business operations.

TPE:3617
Asia

Britannia Industries' Consolidated Profit Rises in Fiscal Q4

Britannia Industries' (NSE:BRITANNIA, BOM:500825) consolidated attributable profit rose to 6.78 billion Indian rupees in the fiscal fourth quarter ended March 31, from 5.60 billion rupees a year ago.Earnings per share came in at 28.16 rupees from 23.25 rupees a year earlier, the fast-moving consumer goods company said in a filing to the Indian stock exchanges on Thursday.Revenue from operations in fiscal Q4 increased to 47.2 billion rupees from 44.3 billion rupees a year ago.The company's board recommended a final dividend of 90.50 rupees per equity share of face value of 1 rupee each for the financial year ended March 31.

BOM:500825NSE:BRITANNIA
Asia

Greentown China Logs 9.6 Billion Yuan in April Sales

Greentown China Holdings (HKG:3900) reported total sales, including contracted and subscription sales, of about 9.6 billion yuan in April, according to a Thursday filing with the Hong Kong bourse.The property developer's shares gained nearly 1% in morning trade on Friday.The group sold 1,742 units of self-investment projects during the month, with a sales area of roughly 260,000 square meters.The average selling price for the month was 36,399 yuan per square meter.Contracted sales in the first four months of 2026 amounted to about 36 billion yuan. As of the end of April, the property firm recorded subscription sales of around 2.2 billion yuan.

HKG:3900